E Elizabeth Patton - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

E Elizabeth Patton

Showing results (101-110 of 105) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 105 results.

Cancer Cell|February 5, 2021

Melanoma models for the next generation of therapiesE Elizabeth Patton, Kristen L Mueller, David J Adams, et al.

Genome Biology|October 24, 2013

The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish modelsJennifer Yen, Richard M White, David C Wedge, et al.

American Journal of Medical Genetics. Part A|December 17, 2009

Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and backKatherine A Rauen, Lisa Schoyer, Frank McCormick, et al.

The Journal of Clinical Investigation|November 2, 2018

Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapyLara Al-Olabi, Satyamaanasa Polubothu, Katherine Dowsett, et al.

The Journal of Clinical Investigation|February 21, 2018

Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapyLara Al-Olabi, Satyamaanasa Polubothu, Katherine Dowsett, et al.

Pageof 11

Search research articles

Showing results (101-110 of 105) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 105 results.

Cancer Cell|February 5, 2021

Melanoma models for the next generation of therapiesE Elizabeth Patton, Kristen L Mueller, David J Adams, et al.

Genome Biology|October 24, 2013

The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish modelsJennifer Yen, Richard M White, David C Wedge, et al.

American Journal of Medical Genetics. Part A|December 17, 2009

Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and backKatherine A Rauen, Lisa Schoyer, Frank McCormick, et al.

The Journal of Clinical Investigation|November 2, 2018

Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapyLara Al-Olabi, Satyamaanasa Polubothu, Katherine Dowsett, et al.

The Journal of Clinical Investigation|February 21, 2018

Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapyLara Al-Olabi, Satyamaanasa Polubothu, Katherine Dowsett, et al.

Pageof 11